Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Sus Scrofa Cerebellum is a biological extract derived from porcine brain tissue, utilized primarily as a standardized allergen and in various therapeutic contexts. It encompasses a range of pharmacological activities including adrenergic agonism and calcium chelation.
Name
Sus Scrofa Cerebellum
Raw Name
SUS SCROFA CEREBELLUM
Category
Standardized Chemical Allergen [EPC]
Drug Count
7
Variant Count
7
Last Verified
February 17, 2026
About Sus Scrofa Cerebellum
Sus Scrofa Cerebellum is a biological extract derived from porcine brain tissue, utilized primarily as a standardized allergen and in various therapeutic contexts. It encompasses a range of pharmacological activities including adrenergic agonism and calcium chelation.
Detailed information about Sus Scrofa Cerebellum
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Cerebellum.
Sus Scrofa Cerebellum refers to a standardized biological extract derived from the cerebellum (the region of the brain responsible for motor control and coordination) of the domestic pig (Sus scrofa). In the landscape of modern pharmacology, this substance is classified under several distinct categories, most notably as a Standardized Chemical Allergen [EPC]. However, its biochemical complexity allows it to be categorized under multiple Established Pharmacologic Classes (EPCs), including Amino Acids, Calculi Dissolution Agents, Anti-coagulants, and both alpha- and beta-Adrenergic Agonists.
Sus Scrofa Cerebellum belongs to a class of drugs called biological extracts or organotherapeutic agents. These substances are derived from animal tissues and are processed to retain specific bioactive molecules, such as peptides, neurotransmitters, and enzymes. While its primary use in conventional Western medicine is often related to allergenic testing and immunotherapy (Non-Standardized Food Allergenic Extract), its presence in various formulations suggests a broader range of therapeutic applications, particularly in integrative and homeopathic pharmacopeias where it is used to support neurological and metabolic functions. The FDA has historically regulated these extracts under the umbrella of allergenic products or as components of homeopathic preparations, which must adhere to the standards set by the Homeopathic Pharmacopoeia of the United States (HPUS).
The mechanism of action (MoA) for Sus Scrofa Cerebellum is multifaceted due to the diverse array of bioactive compounds found within porcine brain tissue. At the molecular level, this extract exhibits Adrenergic alpha-Agonist and Adrenergic beta-Agonist activities. This is primarily attributed to the presence of endogenous catecholamines (such as epinephrine, norepinephrine, and dopamine) naturally found in the cerebellum. These molecules target alpha- and beta-adrenergic receptors throughout the body, influencing heart rate, vascular tone, and metabolic processes.
Furthermore, the extract demonstrates Calcium Chelating Activity [MoA]. Chelation involves the binding of metal ions, such as calcium, which can influence various physiological pathways, including the prevention of mineral crystallization—hence its classification as a Calculi Dissolution Agent. Additionally, its Acidifying Activity [MoA] can alter the pH of specific microenvironments, which may be relevant in the management of certain types of urinary or biliary stones. The anti-coagulant properties are likely linked to specific glycosaminoglycans or heparin-like substances found within the neural tissue matrix, which interfere with the coagulation cascade to prevent or slow the formation of blood clots.
Understanding the pharmacokinetics of a complex biological extract like Sus Scrofa Cerebellum requires looking at its primary active constituents:
Sus Scrofa Cerebellum is utilized in several clinical contexts, though its application depends heavily on the specific formulation:
Sus Scrofa Cerebellum is available in several dosage forms, depending on the intended therapeutic goal:
> Important: Only your healthcare provider can determine if Sus Scrofa Cerebellum is right for your specific condition. The use of animal-derived extracts requires careful clinical oversight to ensure safety and efficacy.
The dosage of Sus Scrofa Cerebellum is highly individualized and depends entirely on the clinical indication and the concentration of the specific extract used.
Sus Scrofa Cerebellum is not routinely approved for pediatric use unless specifically directed by an allergist for immunotherapy. In cases where it is used for children, dosing is calculated based on age, weight, and the severity of the allergic sensitivity. Extreme caution is required due to the risk of anaphylaxis in pediatric populations. For non-allergenic uses, safety and efficacy in children have not been established, and its use is generally discouraged.
Patients with significant renal impairment (CrCl < 30 mL/min) should be monitored closely. While the extract itself is biological, the metabolic byproducts and catecholamine metabolites are cleared renally. Accumulation of these substances could theoretically lead to increased systemic side effects.
No specific dosage adjustments are provided for hepatic impairment; however, since the liver is the primary site for amino acid deamination and COMT-mediated metabolism, patients with severe liver disease should be treated with caution.
Geriatric patients often have a higher sensitivity to adrenergic agonists. Dosing should start at the lower end of the therapeutic range to avoid cardiovascular complications such as hypertension or tachycardia.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. For immunotherapy, missing a dose may require a temporary reduction in the concentration of the next injection to prevent a systemic reaction.
Signs of overdose with Sus Scrofa Cerebellum may include symptoms of adrenergic excess: rapid heartbeat (tachycardia), elevated blood pressure, severe anxiety, tremors, and headache. In the event of an accidental overdose of oral supplements, contact a poison control center immediately. If an overdose occurs during an injection (systemic reaction), emergency medical intervention is required to manage potential anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance, as the biological nature of this product makes precise dosing critical for safety.
Patients taking Sus Scrofa Cerebellum, particularly in the form of allergenic extracts or concentrated glandulars, may experience the following common side effects:
> Warning: Stop taking Sus Scrofa Cerebellum and call your doctor immediately if you experience any of these.
Prolonged use of Sus Scrofa Cerebellum may lead to Sensitization. Instead of becoming desensitized (the goal of immunotherapy), some individuals may develop an increased allergic sensitivity to porcine products. Additionally, chronic exposure to exogenous catecholamines could theoretically lead to down-regulation of adrenergic receptors, though this is more common with synthetic stimulants than with biological extracts.
While Sus Scrofa Cerebellum itself may not have a specific individual black box warning, all Allergenic Extracts carry a general FDA-mandated warning regarding the risk of severe systemic reactions.
Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylactic shock and death. They should only be administered by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients must be observed for at least 30 minutes following an injection. Patients with unstable asthma or those taking beta-blockers may be at increased risk for severe outcomes.
Report any unusual symptoms to your healthcare provider immediately. Monitoring for delayed reactions (up to 24 hours post-administration) is also recommended during the initial phases of therapy.
Sus Scrofa Cerebellum is a complex biological product. Patients must be aware that because it is derived from animal tissue, it contains a variety of proteins and neurotransmitters that can interact with the human body in unpredictable ways. It is not a "simple" drug, and its effects can vary significantly between different manufacturers and batches.
These warnings emphasize that the product must be administered in a setting where emergency care is immediately available. The risk of anaphylaxis is the primary concern. If the product is being used as a dietary supplement or homeopathic remedy, these specific black box warnings may not appear on the label, but the underlying risk of hypersensitivity remains relevant.
Sus Scrofa Cerebellum may cause dizziness or transient changes in blood pressure. Patients should observe how they react to the medication before driving or operating heavy machinery. If jitteriness or tremors occur, these activities should be avoided.
Alcohol should be avoided or strictly limited. Alcohol can exacerbate the cardiovascular side effects of adrenergic agonists and may increase the risk of a severe allergic reaction by increasing peripheral vasodilation.
Do not stop taking Sus Scrofa Cerebellum suddenly if you are using it for immunotherapy, as this can disrupt the desensitization process. For oral supplements, tapering is generally not required unless the patient has been taking very high doses, in which case a gradual reduction over one week is advisable to avoid "rebound" lethargy.
> Important: Discuss all your medical conditions, especially heart disease and allergies, with your healthcare provider before starting Sus Scrofa Cerebellum.
For each major interaction, the mechanism typically involves either Pharmacodynamic Synergi (where two drugs have similar effects that add up to a dangerous level) or Metabolic Inhibition (where one substance prevents the breakdown of another). Management usually involves avoiding the combination or performing frequent cardiovascular monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines which often contain stimulants.
Conditions where Sus Scrofa Cerebellum must NEVER be used include:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to Cat Epithelium or Cat Dander may occasionally show cross-reactivity with porcine albumin (the "pork-cat syndrome"). While Sus Scrofa Cerebellum is a brain extract, it may still contain trace amounts of albumin or related proteins that could trigger a reaction in these sensitive individuals.
> Important: Your healthcare provider will evaluate your complete medical history, including all allergies and cardiovascular risks, before prescribing or recommending Sus Scrofa Cerebellum.
Pregnancy Category: C (According to general standards for animal-derived extracts). There are no adequate and well-controlled studies of Sus Scrofa Cerebellum in pregnant women. Animal reproduction studies have not been conducted. It is unknown whether the extract can cause fetal harm or affect reproduction capacity.
It is not known whether the components of Sus Scrofa Cerebellum are excreted in human milk. Because many drugs and biological proteins are excreted in human milk, caution should be exercised. The nursing infant could theoretically be exposed to catecholamines or immunogenic proteins, which might cause irritability or allergic sensitization. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients below the age of 12 have not been established for non-allergenic uses. For immunotherapy, use in children is common but must be managed by a pediatric allergist. There is a risk of growth suppression with chronic use of potent stimulants, though the levels in this extract are likely too low to cause such an effect. However, the risk of severe systemic reactions is a major concern in children.
Clinical studies of Sus Scrofa Cerebellum did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Elderly patients are at increased risk for falls if the medication causes dizziness or blood pressure fluctuations.
In patients with renal impairment, the clearance of amino acid metabolites and catecholamine byproducts may be reduced. While no specific GFR-based dose adjustments are codified, patients with a GFR < 60 mL/min should be monitored for signs of cumulative toxicity. This product is not known to be cleared by dialysis.
No formal studies have been conducted in patients with hepatic impairment. However, since the liver processes the nitrogenous waste from amino acids and metabolizes catecholamines via COMT, patients with Child-Pugh Class B or C impairment should be monitored for signs of metabolic stress or increased adrenergic sensitivity.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure the safest possible therapeutic outcome.
Sus Scrofa Cerebellum functions through a complex interplay of its biological constituents. Its primary pharmacological identity is derived from its Adrenergic Agonist properties. The extract contains endogenous catecholamines—epinephrine and norepinephrine—which act as ligands for alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors.
The dose-response relationship for Sus Scrofa Cerebellum is non-linear, particularly in its role as an allergen. Small increases in dose can lead to exponentially larger immune responses in sensitized individuals. The time to onset for its adrenergic effects is rapid (15-30 minutes for oral, 5-10 minutes for injection), while its effects on calculi dissolution or immune modulation may take weeks or months of consistent use to manifest. Tolerance to the adrenergic effects can develop with chronic use, a process known as tachyphylaxis.
| Parameter | Value |
|---|---|
| Bioavailability | Variable (Low for large proteins, High for amino acids) |
| Protein Binding | 30-60% (for catecholamine components) |
| Half-life | 2-5 minutes (catecholamines); Hours to days (proteins) |
| Tmax | 0.5 - 2 hours (Oral) |
| Metabolism | Hepatic (COMT, MAO, Deamination) |
| Excretion | Renal (>90% as metabolites) |
Sus Scrofa Cerebellum is classified as a Standardized Chemical Allergen [EPC]. Within the therapeutic hierarchy, it is related to other porcine-derived products such as porcine insulin, pancrelipase, and thyroid (USP). It is also grouped with other brain-derived neurotrophic factors and organotherapeutic extracts used in alternative medicine.
Medications containing this ingredient
Common questions about Sus Scrofa Cerebellum
Sus Scrofa Cerebellum is primarily used in the medical field as a standardized allergen for diagnostic testing and immunotherapy, particularly for individuals with porcine-related sensitivities. In integrative and homeopathic medicine, it is also used as an organotherapeutic extract intended to support neurological health and cerebellar function. Additionally, due to its biochemical properties, it is sometimes utilized in protocols for dissolving mineral calculi (stones) and as a mild anti-coagulant. It contains various bioactive components like amino acids and neurotransmitters that can influence metabolic and cardiovascular processes. Always consult a healthcare provider to understand its specific role in your treatment plan.
The most common side effects of Sus Scrofa Cerebellum depend on how it is administered. For those receiving injections for allergy treatment, local reactions such as redness, itching, and swelling at the site are very frequent. When taken orally as a supplement, patients often report mild gastrointestinal issues like nausea or bloating, as well as transient headaches. Because the extract contains natural stimulants like norepinephrine, some people may also experience a slightly increased heart rate or a feeling of nervousness. Most of these side effects are mild and resolve on their own, but any persistent symptoms should be reported to a doctor.
It is generally advised to avoid or strictly limit alcohol consumption while using Sus Scrofa Cerebellum. Alcohol can interact with the adrenergic components of the extract, potentially leading to unpredictable changes in blood pressure and heart rate. Furthermore, alcohol is a vasodilator, which can increase the speed at which allergens are absorbed into the bloodstream, thereby raising the risk of a severe systemic allergic reaction (anaphylaxis). Alcohol may also worsen the dizziness or headaches that some patients experience while taking this medication. To ensure your safety, discuss your alcohol intake with your prescribing physician.
The safety of Sus Scrofa Cerebellum during pregnancy has not been established through rigorous clinical trials, and it is classified as Pregnancy Category C. This means that while there is no definitive evidence of harm, there is also no guarantee of safety for the developing fetus. The primary concern during pregnancy is the risk of a severe allergic reaction in the mother, which could potentially reduce oxygen delivery to the baby. Additionally, the stimulant effects of the extract could affect maternal blood pressure. Pregnant women should only use this product if their doctor determines that the potential benefits significantly outweigh the risks.
The time it takes for Sus Scrofa Cerebellum to work varies based on the condition being treated. If it is being used for its adrenergic effects (like increasing alertness or vascular tone), the onset is relatively quick, often within 30 to 60 minutes of oral ingestion. However, when used for allergenic immunotherapy, it can take several months of consistent treatment to notice a reduction in allergy symptoms as the immune system slowly desensitizes. For uses related to calculi dissolution or neurological support, several weeks of daily use may be required before any clinical improvement is observed. Patience and consistent dosing are key to seeing results.
Whether you can stop Sus Scrofa Cerebellum suddenly depends on your specific treatment regimen. If you are undergoing allergenic immunotherapy (allergy shots), stopping suddenly can disrupt the desensitization process and may require you to start over at a lower dose later. For those taking it as an oral supplement for general health, stopping suddenly is usually safe, although some people may experience a temporary dip in energy levels if they were taking high doses. You should always consult your healthcare provider before discontinuing any medication to ensure that it is safe for your specific health situation and to discuss any necessary tapering.
If you miss a dose of Sus Scrofa Cerebellum, you should take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule; never take two doses at once to make up for a missed one. For those receiving injections, missing a dose is more critical, as it can increase the risk of a reaction when you resume treatment. If you miss an injection appointment, contact your allergist immediately, as they may need to adjust the concentration of your next dose to maintain safety.
There is currently no clinical evidence to suggest that Sus Scrofa Cerebellum causes weight gain. In fact, because it contains adrenergic agonists (stimulants), it is more likely to slightly increase the metabolic rate, which would not typically lead to weight accumulation. However, everyone's body reacts differently to biological extracts. If you notice unusual weight changes while taking this medication, it is more likely related to other factors such as changes in appetite, fluid retention, or underlying health conditions. You should discuss any significant weight changes with your healthcare provider to determine the underlying cause.
Sus Scrofa Cerebellum can interact with several other medications, particularly those that affect the heart or nervous system. It should not be taken with MAO inhibitors or certain beta-blockers, as these combinations can cause dangerous spikes in blood pressure. It may also interact with antidepressants, thyroid medications, and other stimulants. Because it is a complex biological extract, it has the potential for many interactions that may not be fully documented. Always provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking before starting this treatment.
Sus Scrofa Cerebellum is a biological product rather than a synthetic chemical drug, so the term 'generic' does not apply in the traditional sense. Instead, there are various 'branded' and 'non-branded' versions of porcine cerebellum extracts produced by different laboratory and homeopathic manufacturers. While these products may contain the same primary ingredient, they are not necessarily interchangeable because the concentration and processing methods can vary significantly between brands. If your doctor prescribes a specific formulation, you should not switch to a different version without their approval, as the potency and safety profile may differ.